Synovir thalidomide: CELG announced its plan for a Phase II/III pivotal trial

Celgene Corp. (CELG), Warren, N.J.
Product: Synovir thalidomide
Indication: Aphthous ulcers

Read the full 114 word article

How to gain access

Continue reading with a
two-week free trial.